Bayer said its eye treatment aflibercept showed positive results in a late-stage trial, including improved vision gains for people suffering from some retinal diseases.
Bayer Eye Drug Shows Positive Results in Late-Stage Trial
Related Posts
Japan’s economy is stronger than many realise
December 23, 2024
5:18 am
Sony to Raise Stake in Kadokawa, Becoming a Top Shareholder
December 23, 2024
4:35 am
Calgary firefighters give back during annual toy event | Globalnews.ca
December 23, 2024
12:30 am